CheckMyRecalls

Glenmark Pharmaceuticals Inc., USA recalls Abiraterone Acetate Tablets…

Glenmark Pharmaceuticals Inc., USA recalls Abiraterone Acetate Tablets USP 500 mg

Published
4 Nov 2026
Units affected
1296 bottles
Agency
FDA
Country
United States

The hazard

Labeling: Not Elsewhere Classified

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Abiraterone Acetate Tablets USP 500 mg, 60-count bottles, Rx only, Distributed by: Glenmark Pharmaceuticals USA, Elmwood Park, NJ 07407, NDC 68462-882-60

Brand / company
Glenmark Pharmaceuticals Inc., USA
Codes / lots
Lot #: 13250135, Exp. Date 11/2027
Distribution
Nationwide within the United States
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 4 Nov 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.